1. Home
  2. SILO vs EFSH Comparison

SILO vs EFSH Comparison

Compare SILO & EFSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SILO
  • EFSH
  • Stock Information
  • Founded
  • SILO 2010
  • EFSH 1948
  • Country
  • SILO United States
  • EFSH United States
  • Employees
  • SILO N/A
  • EFSH N/A
  • Industry
  • SILO Apparel
  • EFSH Professional Services
  • Sector
  • SILO Consumer Discretionary
  • EFSH Consumer Discretionary
  • Exchange
  • SILO Nasdaq
  • EFSH Nasdaq
  • Market Cap
  • SILO 4.7M
  • EFSH 5.6M
  • IPO Year
  • SILO N/A
  • EFSH N/A
  • Fundamental
  • Price
  • SILO $0.84
  • EFSH $0.25
  • Analyst Decision
  • SILO
  • EFSH
  • Analyst Count
  • SILO 0
  • EFSH 0
  • Target Price
  • SILO N/A
  • EFSH N/A
  • AVG Volume (30 Days)
  • SILO 596.1K
  • EFSH 2.6M
  • Earning Date
  • SILO 11-12-2024
  • EFSH 11-19-2024
  • Dividend Yield
  • SILO N/A
  • EFSH N/A
  • EPS Growth
  • SILO N/A
  • EFSH N/A
  • EPS
  • SILO N/A
  • EFSH N/A
  • Revenue
  • SILO $72,102.00
  • EFSH $69,415,140.00
  • Revenue This Year
  • SILO $1.86
  • EFSH N/A
  • Revenue Next Year
  • SILO N/A
  • EFSH N/A
  • P/E Ratio
  • SILO N/A
  • EFSH N/A
  • Revenue Growth
  • SILO N/A
  • EFSH 228.22
  • 52 Week Low
  • SILO $0.77
  • EFSH $0.20
  • 52 Week High
  • SILO $4.50
  • EFSH $1,037.40
  • Technical
  • Relative Strength Index (RSI)
  • SILO 40.96
  • EFSH 39.48
  • Support Level
  • SILO $0.77
  • EFSH $0.21
  • Resistance Level
  • SILO $0.99
  • EFSH $0.31
  • Average True Range (ATR)
  • SILO 0.10
  • EFSH 0.05
  • MACD
  • SILO 0.00
  • EFSH 0.73
  • Stochastic Oscillator
  • SILO 23.30
  • EFSH 35.23

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

About EFSH 1847 Holdings LLC

1847 Holdings LLC is a diversified holding company. It operates in Four segments: Retail and appliances, Retail and Eyewear, Construction, and Automotive Supplies. The company generates maximum revenue from the Construction segment. The firm, through its subsidiaries, provides a wide range of land application services and sells equipment and parts, primarily to the agricultural, construction, and lawn and garden industries.

Share on Social Networks: